Despite COVID-19, Expert Group Moves Ahead With Public Meeting On Pediatric Device Development
Executive Summary
While the US FDA has been developing a framework over the past few years to address the lack of pediatric devices on the market, the agency awarded a grant to the multi-stakeholder group C-Path to continue that work at the same time that the coronavirus pandemic started. Despite the hurdles, C-Path says it is still doing its work and plans to convene a public meeting on the issue in September.
You may also be interested in...
FDA To Hold Postponed 3-Day Pediatric Device Workshop In February
The US agency plans to hold a virtual workshop that will use breakout sessions to get stakeholder feedback on specific hurdles preventing more pediatric devices coming to market.
Better Reimbursement, More Incentives Needed For Peds Device Development, Stakeholders Tell FDA
At a recent pediatric medical devices workshop at US FDA headquarters, the focus turned less to regulatory burdens and more to lacking reimbursement and financial incentives as barriers to bringing child-focused products to market.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.